BeOne Medicines Ltd.
ONC· Nasdaq
BeOne Medicines Ltd.
- Last sale
- Oct 1, 2026 · -1.95%
- Market cap
- $530.66B
- 1.48B shares
- Filings
- 1,046
Price
Oct 1, 2026 · IEX last sale
IEX last saleClose of recordAs traded
Last sale prices: Data provided for free by IEX. By accessing or using IEX Historical Data, you agree to the IEX Historical Data Terms of Use.
Financials
Revenue
| Period | Ended | Value | Kind | Source trail |
|---|---|---|---|---|
| FY 2025 | 2025-12-31 | $5,343,033,000 | reported | |
| FY 2024 | 2024-12-31 | $3,810,241,000 | reported | |
| FY 2023 | 2023-12-31 | $2,458,779,000 | reported | |
| FY 2022 | 2022-12-31 | $1,415,921,000 | reported | |
| FY 2021 | 2021-12-31 | $1,176,283,000 | reported | |
| FY 2020 | 2020-12-31 | $308,874,000 | reported | |
| FY 2019 | 2019-12-31 | $428,212,000 | reported | |
| FY 2018 | 2018-12-31 | $198,220,000 | reported | |
| FY 2017 | 2017-12-31 | $238,387,000 | reported | |
| FY 2016 | 2016-12-31 | $1,070,000 | reported | |
| FY 2015 | 2015-12-31 | $8,816,000 | reported | |
| FY 2014 | 2014-12-31 | $13,035,000 | reported |
BeOne Medicines Ltd. · CIK 1651308 · Engraved from SEC EDGAR
